Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:2669-2677, 2006
DOI: 10.2337/db06-0389
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Appendix Only
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, S. L.
Right arrow Articles by Vidal-Puig, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Leptin Deficiency Unmasks the Deleterious Effects of Impaired Peroxisome Proliferator–Activated Receptor {gamma} Function (P465L PPAR{gamma}) in Mice

Sarah L. Gray1, Edoardo Dalla Nora1, Johannes Grosse2, Monia Manieri3, Tobias Stoeger4, Gema Medina-Gomez1, Keith Burling1, Sigrid Wattler2, Andreas Russ5, Giles S.H. Yeo1, V. Krishna Chatterjee6, Stephen O’Rahilly1,6, Peter J. Voshol7, Saverio Cinti3, and Antonio Vidal-Puig1,6

1 Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K
2 Ingenium Pharmaceuticals, Martinsried, Germany
3 Department of Normal Human Morphology, Faculty of Medicine, Ancona University, Ancona, Italy
4 GSF-National Research Center for Environment and Health, Institute of Inhalation Biology, Muenchen-Neuherberg, Germany
5 Genetics Unit, Department of Biochemistry, University of Oxford, Oxford, U.K
6 Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K
7 TNO-Prevention and Health, Division VBO, Leiden, the Netherlands

Address correspondence and reprint requests to Antonio Vidal-Puig, Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QR, U.K. E-mail: ajv22{at}cam.ac.uk

Abbreviations: gWAT, gonadal white adipose tissue; PPAR, peroxisome proliferator–activated receptor; scWAT, subcutaneous white adipose tissue; WAT, white adipose tissue

Peroxisome proliferator–activated receptor (PPAR){gamma} is a key transcription factor facilitating fat deposition in adipose tissue through its proadipogenic and lipogenic actions. Human patients with dominant-negative mutations in PPAR{gamma} display lipodystrophy and extreme insulin resistance. For this reason it was completely unexpected that mice harboring an equivalent mutation (P465L) in PPAR{gamma} developed normal amounts of adipose tissue and were insulin sensitive. This finding raised important doubts about the interspecies translatability of PPAR{gamma}-related findings, bringing into question the relevance of other PPAR{gamma} murine models. Here, we demonstrate that when expressed on a hyperphagic ob/ob background, the P465L PPAR{gamma} mutant grossly exacerbates the insulin resistance and metabolic disturbances associated with leptin deficiency, yet reduces whole-body adiposity and adipocyte size. In mouse, coexistence of the P465L PPAR{gamma} mutation and the leptin-deficient state creates a mismatch between insufficient adipose tissue expandability and excessive energy availability, unmasking the deleterious effects of PPAR{gamma} mutations on carbohydrate metabolism and replicating the characteristic clinical symptoms observed in human patients with dominant-negative PPAR{gamma} mutations. Thus, adipose tissue expandability is identified as an important factor for the development of insulin resistance in the context of positive energy balance.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. L. Gray, E. Dalla Nora, E. C. Backlund, M. Manieri, S. Virtue, R. C. Noland, S. O'Rahilly, R. N. Cortright, S. Cinti, B. Cannon, et al.
Decreased Brown Adipocyte Recruitment and Thermogenic Capacity in Mice with Impaired Peroxisome Proliferator-Activated Receptor (P465L PPAR{gamma}) Function
Endocrinology, December 1, 2006; 147(12): 5708 - 5714.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.